Microbiome Composition Changes on 4 Week Gluten-free Diet Challenge
Study Details
Study Description
Brief Summary
Changes in the gut microbiomes of healthy volunteers who followed a gluten-free diet (GFD) for four weeks were studied. Per participant, nine stool samples were collected: one at baseline, four during the GFD period, and four when they returned to their habitual diet. Microbiome profiles were determined using 16S rRNA sequencing and the samples were next processed for taxonomic and imputed functional composition. Additionally, participants kept a 3-day food diary and six gut health-related biomarkers were measured.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: GFD After instruction of a dietician, participants adhered to a gluten-free diet for 4 weeks. |
Other: Dietary intervention
|
Outcome Measures
Primary Outcome Measures
- Changes in gut microbiota composition upon gluten-free diet intervention [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
Secondary Outcome Measures
- Changes in gut associated biomarker levels: fecal calprotectin [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
- Changes in gut associated biomarker levels: plasma cytokines: IL-1beta [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
- Changes in gut associated biomarker levels: fecal human beta defensin 2 [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
- Changes in gut associated biomarker levels: fecal chromogranin A [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
- Changes in gut associated biomarker levels: fecal short chain fatty acids: propionate [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
- Changes in gut associated biomarker levels: plasma citrulline [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
- Changes in gut associated biomarker levels: fecal short chain fatty acids: acetate [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
- Changes in gut associated biomarker levels: fecal short chain fatty acids: butyrate [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
- Changes in gut associated biomarker levels: fecal short chain fatty acids: valerate [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
- Changes in gut associated biomarker levels: fecal short chain fatty acids: caproate [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
- Changes in gut associated biomarker levels: plasma cytokines: IL-6 [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
- Changes in gut associated biomarker levels: plasma cytokines: IL-8 [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
- Changes in gut associated biomarker levels: plasma cytokines: IL-10 [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
- Changes in gut associated biomarker levels: plasma cytokines: IL-12 [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
- Changes in gut associated biomarker levels: plasma cytokines: TNFalpha [baseline, 4 weeks gluten-free diet and 4 weeks habitual diet]
Eligibility Criteria
Criteria
Inclusion Criteria:
- healthy participants aged >=16
Exclusion Criteria:
-
Known gastrointestinal disorder
-
Known food intolerance
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Medical Center Groningen | Groningen | Netherlands | 9700 RB |
Sponsors and Collaborators
- University Medical Center Groningen
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- M12.113965